Results 341 to 350 of about 1,515,008 (404)

Coronary Heart Disease Risk: Low-Density Lipoprotein and Beyond.

Trends in cardiovascular medicine, 2021
Coronary heart disease (CHD) is the leading cause of morbidity and mortality world-wide and has been characterized as a chronic immunoinflammatory, fibroproliferative disease fueled by lipids.
G. Shaya   +4 more
semanticscholar   +1 more source

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
José Luis, Sánchez-Quesada   +2 more
openaire   +2 more sources

Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol

Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire   +2 more sources

Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein

Pathophysiology of Haemostasis and Thrombosis, 2006
Cardiovascular disease is the main cause of death and disability in the Western society. Lipoproteins are important in the development of cardiovascular disease since they change the properties of different cells involved in atherosclerosis and thrombosis. The interaction of platelets with lipoproteins has been under intense investigation. Particularly
Suzanne J A, Korporaal   +1 more
openaire   +2 more sources

On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein

Lipids and Lipid Metabolism, 1973
Abstract The relationship of 125I-labelled apoproteins of very low density lipoprotein to that of other lipoproteins was studied in humans during steady-state conditions and following heparin injection. Heterogeneous metabolism of very low density lipo-protein apoproteins in normal individuals was apparent during steady-state conditions ...
S Eisenberg, R I Levy, F T Lindgren
exaly   +3 more sources

The low density lipoprotein receptor

Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1989
The study of familial hypercholesterolemia at the molecular level has led to its advancement from a clinical syndrome to a fascinating experimental system. FH was first described 50 years ago by Carl Müller who concluded that the disease produces high plasma cholesterol levels and myocardial infarctions in young people, and is transmitted as an ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy